Oyster Therapeutics
Oyster Therapeutics

Oyster Therapeutics

Measured by StartupHub.aiAgent51 out of 100, Top 25%. Agent Readiness. Open the scores section.Agent Readiness: 51/100. Top 25%. Measured by StartupHub.ai. Median 41.Measured by StartupHub.aiTrust76 out of 100, Above median. Data Trust. Open the scores section.Data Trust: 76/100. Above median. Measured by StartupHub.ai. Median 61.

Oyster Therapeutics is a London-based pharmaceutical company developing next-generation targeted protein degraders with an initial focus on tau-driven neurodegenerative diseases such as Alzheimer's. Its proprietary SELFTAC platform transforms large bifunctional degraders into small molecules via a reversible linker to enable oral bioavailability and CNS penetration.

ActiveLondon, United Kingdom

About

Oyster Therapeutics is a London-based pharmaceutical company developing next-generation targeted protein degraders with an initial focus on tau-driven neurodegenerative diseases such as Alzheimer's. Its proprietary SELFTAC platform transforms large bifunctional degraders into small molecules via a reversible linker to enable oral bioavailability and CNS penetration. Its lead program is a small-molecule oral degrader designed to selectively clear pathological tau while preserving healthy tau, advanced in collaboration with Massachusetts General Hospital.

Key facts

Website
oyster-tx.com
Headquarters
London, United Kingdom
Total funding
$98M (Series A)
Business model
B2B

Funding rounds

Funding rounds raised by Oyster Therapeutics
DateRoundAmountLead investors
10 Nov 2026Series A$60M
1 Jan 2023Series A$6M
1 Jan 2022Series A$32M

Tech stack

Detected on oyster-tx.com, last scanned 12 Nov 2026.

Analytics
Google Tag Manager
CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Microsoft 365
Run your own scan

Test your Agent Readiness

How well ChatGPT, Claude and the other agents can read and use a site. About a minute.

Write the first review

Frequently asked

Is Oyster Therapeutics trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Oyster Therapeutics is 76 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Oyster Therapeutics raised?

Oyster Therapeutics has raised a total of $98M in funding. The most recent round on record is Series A.

SEC filings, insider activity, nonprofit links and pay benchmarks for Oyster Therapeutics:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules